Current and future treatment options for managing hyperkalemia

Area of Science:

• Nephrology
• Cardiology
• Internal Medicine

Background:

• Hyperkalemia is a critical condition associated with severe cardiac arrhythmias and increased mortality.
• It commonly affects patients with chronic kidney disease (CKD) and/or congestive heart failure (CHF).
• Patients on medications that limit renal potassium excretion, particularly renin-angiotensin-aldosterone system inhibitors, are at higher risk.

Purpose of the Study:

• To review the challenges and current treatment strategies for hyperkalemia.
• To highlight the unmet needs in managing hyperkalemia, especially in vulnerable patient populations.
• To discuss the limitations of existing acute and chronic hyperkalemia treatments.

Main Methods:

• Literature review of existing studies and clinical guidelines on hyperkalemia management.
• Analysis of treatment options for both acute and chronic hyperkalemia.
• Discussion of patient populations at risk and associated comorbidities.

Main Results:

• Hyperkalemia management requires both acute interventions for rapid potassium reduction and chronic strategies for stabilization.
• Current treatments, while available, can have complex administration or significant side effects.
• CKD and cardiovascular disease significantly complicate hyperkalemia treatment.

Conclusions:

• Hyperkalemia remains a significant clinical challenge, particularly for patients with CKD and cardiovascular disease.
• There is a need for improved, safer, and more manageable treatment options for hyperkalemia.
• Effective management is crucial to reduce mortality and prevent life-threatening cardiac events.